Cyberbit Ltd., a Ra’Anana, Israel-based provider of cyber range training and simulation platforms, announced that Charlesbank Technology Opportunities Fund, a fund managed by Charlesbank Capital Partners, has invested $70m in the company, a combination of a primary investment and a secondary purchase from Elbit Systems Ltd.


Meridian Bioscience, Inc. (NASDAQ: VIVO), a Cincinnati, OH-based provider of diagnostic testing solutions and life science raw materials, completed the acquisition of Exalenz Bioscience Ltd., a Modiin, Israel based provider of a urea breath test platform for the detection of Helicobacter pylori.